The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer

Interactive Cardiovascular and Thoracic Surgery

Volumn 9, Issue 1, 2009, Pages 79-82

  Maeda, Ryo ^a   Isowa, Noritaka ^a   Onuma, Hideyuki ^a   Miura, Hiroshi ^a   Harada, Tomoya ^a   Touge, Hirokazu ^a   Tokuyasu, Hirokazu ^a   Kawasaki, Yuji ^a  

^a MATSUE RED CROSS HOSPITAL   (Japan)

Author keywords

FDG PET; Non small cell lung cancer; SUV; Thoracic surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18; ANTIGEN CYFRA21.1; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR CELL; BLOOD; BLOOD VESSEL; BODY WEIGHT; CANCER STAGING; COMPARATIVE STUDY; DATA BASE; LUNG RESECTION; LUNG TUMOR; LYMPHADENECTOMY; METASTASIS; MIDDLE AGED; PATHOLOGY; PLEURA; PREDICTION AND FORECASTING; SCINTISCANNING; STANDARD; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BLOOD VESSELS; BODY WEIGHT; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; DATABASES AS TOPIC; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KERATIN-19; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PLEURA; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; THORACOTOMY;

EID: 67650169894     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.201251     Document Type: Article

References (15)

1. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;217:251-256.
2. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg 1999;117:1102-1111. (Pubitemid 29270349)
3. Tsubota N, Ayabe K, Doi O, Mori T, Namikawa S, Taki T, Watanabe Y. Ongoing prospective study of segmentectomy for small lung tumors. Study Group of Extended Segmentectomy for Small Lung Tumor. Ann Thorac Surg 1998;66:1787-1790. (Pubitemid 29030190)
4. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-623.
5. Ichinose Y, Yano T, Yokoyama H, Inoue T, Asoh H, Katsuda Y. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection. J Thorac Cardiovasc Surg 1994;108:684-686. (Pubitemid 24330245)
6. Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with non-small cell carcinoma. Ann Thorac Surg 2003;76:861-866. (Pubitemid 37100761)
7. Dhital K, Saunders CA, Seed PT, O'Doherty MJ, Dussek J. [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 2000;18:425-428.
8. Hanin FX, Lonneux M, Cornet J, Noirhomme P, Coulon C, Distexhe J, Poncelet AJ. Prognostic value of FDG uptake in early stage non-small cell lung cancer. Eur J Cardiothorac Surg 2008;33:819-823.
9. Al-Sarraf N, Gately K, Lucey J, Aziz R, Doddakula K, Wilson L, McGovern E, Young V. Clinical implication and prognostic significance of standardized uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases. Eur J Cardiothorac Surg 2008;34:892-897.
10. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005;130:151-159. (Pubitemid 40941684)
11. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization classification of tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart. IARC Press: Lyon; 2004.
12. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15:4-9.
13. Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg 1997;114: 347-353. (Pubitemid 27400867)
14. Whitson BA, Groth SS, Duval SJ, Swanson SJ, Maddaus MA. Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann Thorac Surg 2008;86:2008-2016.
15. Sakuraba M, Miyamoto H, Oh S, Shiomi K, Sonobe S, Takahashi N, Imashimizu K, Sakao Y. Video-assisted thoracoscopic lobectomy vs. conventional lobectomy via open thoracotomy in patients with clinical stage IA non-small cell lung carcinoma. Interact Cardiovasc Thorac Surg 2007;6:614-617. (Pubitemid 47598512)